Moderna
MRNA
#1159
Rank
C$27.76 B
Marketcap
C$70.01
Share price
0.39%
Change (1 day)
87.95%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -C$3.85 Billion

According to Moderna 's latest financial reports the company's current earnings are C$1.92 Billion. , an increase over its 2024 earnings that were of -C$4.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -C$3.8 Billion-23.03%
2024 -C$4.94 Billion-8.22%
2023 -C$5.38 Billion-140.65%
2022 C$13.21 B-27.81%
2021 C$18.30 B-1911.15%
2020 -C$1.02 Billion44.7%
2019 -C$0.7 Billion28.63%
2018 -C$0.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$46.16 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.50 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$30.85 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$65.27 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.47 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.79 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.47 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA